BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  NanoString to Release Fourth Quarter and Fiscal Year 2021 Operating Results and Host Conference Call on Tuesday, March 1, 2022

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that the Company will release fourth quarter and fiscal year 2021 operating results after the close of the market on Tuesday, March 1, 2022.

  February 7, 2022

   · 

  2 min read
• Business

  Emergent BioSolutions to Release Fourth Quarter 2021 Financial Results and Conduct Conference Call on February 24, 2022

  Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, February 24, 2022 at 5:00 pm eastern time to discuss the financial results for the fourth quarter 2021, recent business developments, financial outlook for full year 2022, and revenue guidance for the first quarter of 2022.

  February 7, 2022

   · 

  1 min read
• Deals

  Zimmer Biomet Announces Expected Completion Date of March 1, 2022 for Spinoff of ZimVie

  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that its Board of Directors has declared a pro rata dividend of 80.3% of the outstanding common stock of ZimVie Inc.

  February 7, 2022

   · 

  11 min read
• Lone Star Bio

  Plus Therapeutics to Present at BIO CEO & Investor Conference

  Plus Therapeutics, Inc. announced that Marc H. Hedrick M.D., President and Chief Executive Officer of Plus Therapeutics, will present a company overview during the BIO CEO & Investor Conference on Monday, February 14, 2022 at 1:15 p.m. ET, at the New York Marriott Marquis.

  February 7, 2022

   · 

  4 min read
• Genetown

  Akouos Presents Nonclinical Data Demonstrating Potential Applicability of Precision Genetic Medicine Platform for a Broad Range of Inner Ear Conditions

  Akouos, Inc. presented nonclinical data at the Association for Research in Otolaryngology (ARO) 45th Annual Mid-Winter Meeting that support future development of gene therapies targeting inner ear conditions.

  February 7, 2022

   · 

  5 min read
• Genetown

  Orchard Therapeutics Announces Multiple Presentations at WORLDSymposium™ 2022

  Orchard Therapeutics, a global gene therapy leader, outlined five upcoming presentations from across its neurodegenerative portfolio to be featured at the 18th Annual WORLDSymposium™ being held on February 7-11, 2022.

  February 7, 2022

   · 

  7 min read
• Business

  Zimmer Biomet Announces Fourth Quarter and Full-Year 2021 Financial Results

  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter and year ended December 31, 2021.

  February 7, 2022

   · 

  38 min read
• Evogene to Present at Aegis Virtual Conference

  Evogene Ltd. announced today that it will present a company overview at the Aegis Capital Corp. Virtual Conference to be held on February 25th at 9:00 Eastern.

  February 7, 2022

   · 

  2 min read
• Business

  Cyteir Therapeutics Announces the Appointment of John F. Thero to Board of Directors

  Cyteir Therapeutics, Inc. today announced the appointment of John F. Thero to its board of directors.

  February 7, 2022

   · 

  5 min read
• BioMidwest

  Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2022 MedTech R&D Spotlight Call Series

  Inspire Medical Systems, Inc. announced that its management team will be participating in the Wells Fargo 2022 MedTech R&D Spotlight Call Series on February 18, 2022.

  February 7, 2022

   · 

  1 min read